Demaria and co-workers demonstrated that ABT263 administration efficiently eliminates senescent cells after DOXO injection in transgenic p16-3MR tumour-bearing mice, in which p16INK4 positive cells can be detected using live imaging techniques. The gene discussed is CDKN2A; the disease is neoplasm.